rs146199695

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_030928.4(CDT1):​c.1472G>A​(p.Ser491Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00107 in 1,612,922 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0053 ( 7 hom., cov: 34)
Exomes 𝑓: 0.00062 ( 8 hom. )

Consequence

CDT1
NM_030928.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.86

Publications

1 publications found
Variant links:
Genes affected
CDT1 (HGNC:24576): (chromatin licensing and DNA replication factor 1) The protein encoded by this gene is involved in the formation of the pre-replication complex that is necessary for DNA replication. The encoded protein can bind geminin, which prevents replication and may function to prevent this protein from initiating replication at inappropriate origins. Phosphorylation of this protein by cyclin A-dependent kinases results in degradation of the protein. [provided by RefSeq, Mar 2011]
CDT1 Gene-Disease associations (from GenCC):
  • Meier-Gorlin syndrome 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Meier-Gorlin syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0040723085).
BP6
Variant 16-88807477-G-A is Benign according to our data. Variant chr16-88807477-G-A is described in ClinVar as Benign. ClinVar VariationId is 434678.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00534 (814/152344) while in subpopulation AFR AF = 0.0186 (774/41580). AF 95% confidence interval is 0.0175. There are 7 homozygotes in GnomAd4. There are 396 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDT1NM_030928.4 linkc.1472G>A p.Ser491Asn missense_variant Exon 9 of 10 ENST00000301019.9 NP_112190.2 Q9H211

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDT1ENST00000301019.9 linkc.1472G>A p.Ser491Asn missense_variant Exon 9 of 10 1 NM_030928.4 ENSP00000301019.4 Q9H211
CDT1ENST00000569140.1 linkc.*135G>A downstream_gene_variant 3 ENSP00000456926.1 H3BSY1

Frequencies

GnomAD3 genomes
AF:
0.00533
AC:
812
AN:
152226
Hom.:
7
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0186
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00621
GnomAD2 exomes
AF:
0.00180
AC:
448
AN:
248726
AF XY:
0.00133
show subpopulations
Gnomad AFR exome
AF:
0.0232
Gnomad AMR exome
AF:
0.00191
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000447
Gnomad OTH exome
AF:
0.000658
GnomAD4 exome
AF:
0.000624
AC:
911
AN:
1460578
Hom.:
8
Cov.:
33
AF XY:
0.000551
AC XY:
400
AN XY:
726588
show subpopulations
African (AFR)
AF:
0.0217
AC:
726
AN:
33468
American (AMR)
AF:
0.00165
AC:
74
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86234
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52512
Middle Eastern (MID)
AF:
0.00107
AC:
6
AN:
5632
European-Non Finnish (NFE)
AF:
0.0000207
AC:
23
AN:
1111840
Other (OTH)
AF:
0.00133
AC:
80
AN:
60350
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
55
110
164
219
274
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00534
AC:
814
AN:
152344
Hom.:
7
Cov.:
34
AF XY:
0.00532
AC XY:
396
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.0186
AC:
774
AN:
41580
American (AMR)
AF:
0.00131
AC:
20
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68022
Other (OTH)
AF:
0.00615
AC:
13
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
44
88
131
175
219
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00293
Hom.:
7
Bravo
AF:
0.00646
ESP6500AA
AF:
0.0146
AC:
64
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00200
AC:
242
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Apr 19, 2017
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CDT1-related disorder Benign:1
Aug 14, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
20
DANN
Benign
0.93
DEOGEN2
Benign
0.27
T
Eigen
Benign
-0.84
Eigen_PC
Benign
-0.80
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.55
T
MetaRNN
Benign
0.0041
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.5
L
PhyloP100
1.9
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-1.5
N
REVEL
Benign
0.056
Sift
Benign
0.071
T
Sift4G
Benign
0.17
T
Polyphen
0.0030
B
Vest4
0.25
MVP
0.73
MPC
0.013
ClinPred
0.0056
T
GERP RS
0.98
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.11
gMVP
0.33
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146199695; hg19: chr16-88873885; COSMIC: COSV107369284; COSMIC: COSV107369284; API